Insider · CIK 0001218180
Artal International S.C.A.
Files at LXRX (LEXICON PHARMACEUTICALS, INC.), CAVA (CAVA GROUP, INC.). First filing Nov 20, 2024, latest Nov 20, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CAVA: CAVA GROUP, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 65Notable | CAVA GROUP, INC. | $1.1B 8,000,000 shares | -46% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 18, 2024 | CAVA CAVA GROUP, INC. | 8,000,000 6.98% of outstanding | $1.1B | Nov 18, 2024 | $698M |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | CAVA CAVA GROUP, INC. | SOpen-market sale Common Stock | -8,000,000 | $134.13 | $1.1B | 9,507,990 | Nov 20, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.